Biodesix publishes data on new covid-19 artificial intelligence (ai)-based algorithm for use in clinical decision support systems

Boulder, co.--(business wire)--biodesix, inc. (nasdaq: bdsx), a leading data-driven diagnostic solutions company with a focus in lung disease, today announced a publication describing the development of a new ai-based covid-19 algorithm and the important data from a related study. the paper, entitled, “predicting prognosis in covid-19 patients using machine learning and readily available clinical data,” demonstrates the ai-based algorithm's ability to rapidly and accurately help physicians pred
BDSX Ratings Summary
BDSX Quant Ranking